A study at Duquesne University found that black cohosh, commonly used for menopausal symptoms, may promote progression to metastatic disease in women with early stage breast cancer. The research suggests women who develop breast cancer or are at high risk should proceed with caution or avoid taking the herbal extract.
Researchers have developed a new generation of targeted cancer therapies using bispecific antibodies that target multiple proteins in cancer cells, increasing radiation sensitivity and specificity. The therapy is expected to improve treatment outcomes for patients with breast and ovarian cancers.
Researchers at Wake Forest University Baptist Medical Center have found that oxaliplatin can effectively treat human cancers resistant to other platinum-based therapies. The drug works differently than cisplatin and shows promise in combination with radiation therapy for patients with earlier stages of rectal cancer.
Researchers have discovered a new bone-targeted mTOR inhibitor that decreases both tumor proliferation and bone breakdown for the treatment of bone cancer. Additionally, studies have shown efficacy of radioimmunotherapy using radiolabeled HerceptinTM in combination with gemcitabine in treating intraperitoneal disease.
A new study suggests that telomere dysfunction may play a causal role in human intraepithelial neoplasia (IEN) found in precancers. Short telomeres were found in the majority of precursor lesions across various types of cancers, indicating potential early molecular mechanisms underlying cancer development.